Caricamento...
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
BACKGROUND: Laquinimod is an immunomodulatory drug under clinical investigation for the treatment of the progressive form of multiple sclerosis (MS) with both anti-inflammatory and neuroprotective effects. Excitotoxicity, a prominent pathophysiological feature of MS and of its animal model, experime...
Salvato in:
| Pubblicato in: | J Neuroinflammation |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756343/ https://ncbi.nlm.nih.gov/pubmed/29304807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-1048-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|